Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose Escalation Study of CD19 Chimeric Antigen Receptor (CAR) T Cells With a CD34 Selection Marker in Adults With Recurrent or Refractory B Cell Malignancies

NCT04214886 is registered in ClinicalTrials.gov with Loyola University as lead sponsor.

NCT NCT04214886
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04214886 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose Escalation Study of CD19 Chimeric Antigen Receptor (CAR) T Cells With a CD34 Selection Marker in Adults With Recurrent or Refractory B Cell Malignancies
Lead sponsor
Loyola University
Phase
Phase 1
Overall status
Active, not recruiting
Start date
December 31, 2019
Completion date
December 31, 2034
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

b-cell acute lymphoblastic leukemia, adult, b-cell lymphoma recurrent, b-cell lymphoma refractory